Longevity Health Holdings Statistics
Total Valuation
XAGE has a market cap or net worth of $3.78 million. The enterprise value is $2.60 million.
Important Dates
The next estimated earnings date is Tuesday, August 26, 2025, after market close.
| Earnings Date | Aug 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
XAGE has 1.48 million shares outstanding. The number of shares has increased by 40.07% in one year.
| Current Share Class | 1.48M |
| Shares Outstanding | 1.48M |
| Shares Change (YoY) | +40.07% |
| Shares Change (QoQ) | +42.27% |
| Owned by Insiders (%) | 7.65% |
| Owned by Institutions (%) | 10.48% |
| Float | 1.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.18 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.48 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.47
| Current Ratio | 0.47 |
| Quick Ratio | 0.28 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -261.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -82.71% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 181.32% |
| Revenue Per Employee | $70,131 |
| Profits Per Employee | -$479,005 |
| Employee Count | 15 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.70 |
Taxes
| Income Tax | -97,279 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.50% in the last 52 weeks. The beta is 0.51, so XAGE's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | -91.50% |
| 50-Day Moving Average | 2.97 |
| 200-Day Moving Average | 6.44 |
| Relative Strength Index (RSI) | 42.57 |
| Average Volume (20 Days) | 60,314 |
Short Selling Information
The latest short interest is 25,245, so 1.70% of the outstanding shares have been sold short.
| Short Interest | 25,245 |
| Short Previous Month | 141,557 |
| Short % of Shares Out | 1.70% |
| Short % of Float | 1.84% |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, XAGE had revenue of $1.05 million and -$7.19 million in losses. Loss per share was -$7.99.
| Revenue | 1.05M |
| Gross Profit | 604,414 |
| Operating Income | -5.79M |
| Pretax Income | n/a |
| Net Income | -7.19M |
| EBITDA | -5.71M |
| EBIT | -5.79M |
| Loss Per Share | -$7.99 |
Full Income StatementBalance Sheet
The company has $1.55 million in cash and $371,435 in debt, giving a net cash position of $1.18 million or $0.80 per share.
| Cash & Cash Equivalents | 1.55M |
| Total Debt | 371,435 |
| Net Cash | 1.18M |
| Net Cash Per Share | $0.80 |
| Equity (Book Value) | -3.74M |
| Book Value Per Share | -2.52 |
| Working Capital | -3.67M |
Full Balance SheetCash Flow
| Operating Cash Flow | -3.76M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.07M |
| FCF Per Share | -$2.74 |
Full Cash Flow StatementMargins
| Gross Margin | 57.46% |
| Operating Margin | -550.59% |
| Pretax Margin | -692.26% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |